Free Trial
→ Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (From Colonial Metals) (Ad)

20 Stocks Wall Street Analysts Love the Most - 18 of 20

Slide 18
Back to 17
Continue to 19
 
Back to 17
Continue to 19
 

ADMA Biologics (NASDAQ:ADMA)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$21.25 (0.2% Downside)

About ADMA Biologics

ADMA Biologics logoADMA Biologics, Inc, a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/8/2024HC WainwrightBoost Price TargetBuy ➝ Buy$18.00 ➝ $26.00
11/8/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$18.00 ➝ $25.00
10/14/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
9/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$20.00 ➝ $20.00
8/12/2024HC WainwrightBoost Price TargetBuy ➝ Buy$10.00 ➝ $18.00
8/9/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$15.00 ➝ $20.00
7/9/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$10.00 ➝ $15.00
6/20/2024MizuhoBoost Price TargetBuy ➝ Buy$12.00 ➝ $14.00
5/10/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$8.00 ➝ $10.00
5/10/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$8.00 ➝ $10.00
Slide 18
Back to 17
Continue to 19
 

This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

More From MarketBeat
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Top Ten Brokerages You Can Trust
There are more than 500 brokerages and research houses that hire analysts to issue ratings and recommendations...
MarketBeat
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
7 Stocks to Buy Ahead of a Possible September Rate Cut
According to the CME Group's FedWatch Tool, there is a 57% chance that the Federal Reserve will cut interest r...
MarketBeat
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
7 Restaurant Stocks to Profit from the Trend Towards Fast Casual
If you're a data-driven investor, you may be surprised to learn that fast-casual restaurant stocks are some of...
MarketBeat